Periostin defines a pathological fibroblast program enriched in restrictive allograft syndrome

Area of Science:

• Immunology
• Pulmonary Medicine
• Transplantation Science

Background:

• Chronic lung allograft dysfunction (CLAD) is a major complication after lung transplantation.
• Fibrotic restrictive CLAD is a leading cause of mortality in lung transplant recipients.
• The cellular and molecular mechanisms underlying fibrotic CLAD remain incompletely understood.

Purpose of the Study:

• To identify key cellular players involved in the pathogenesis of fibrotic restrictive CLAD.
• To elucidate the role of specific fibroblast populations in allograft fibrosis.

Main Methods:

• Utilized single-cell RNA sequencing and spatial transcriptomics.
• Analyzed lung allograft biopsies from patients with and without fibrotic restrictive CLAD.
• Immunohistochemistry and immunofluorescence staining for specific markers.

Main Results:

• Identified a distinct population of POSTN-positive pathological fibroblasts.
• These fibroblasts were significantly enriched in fibrotic lung allografts.
• Demonstrated that POSTN-positive fibroblasts are associated with increased extracellular matrix deposition and fibrotic remodeling.

Conclusions:

• POSTN-positive pathological fibroblasts are critical drivers of fibrotic restrictive CLAD.
• Targeting these fibroblasts may represent a novel therapeutic strategy to prevent or treat CLAD.
• Further research is warranted to explore the therapeutic potential of targeting POSTN-positive fibroblasts.